Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3

Name: Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3
Published: 2013
License: Public Domain

Gilead Sciences · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

2)hepatitisc treatment

hepatitis c, hcv genotype 2 (gt-2), hcv genotype 3 (gt-3), hcv, sustained virologic response, direct acting antiviral, combination therapy, treatment-naïve, gs-7977, ribavirin, rbv, peginterferon alfa 2a

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 887881
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.